Magnetic resonance spectroscopic imaging

IEEE Engineering in Medicine and Biology Magazine

Volumn 23, Issue 5, 2004, Pages 30-39

  Nelson, Sarah J ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Fox Chase Institute for Cancer   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Dept of Adv Imaging in Radiology ^*  (United States)

^e Division of Bioengineering   (United States)

^f M Hart Surbeck Lab Adv Imaging   (United States)

^g CA Inst Quantit Biomed Res (QB3)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

BLOOD VESSEL PERMEABILITY; BRACHYTHERAPY; BRAIN BLOOD VOLUME; BRAIN REGION; BRAIN SURGERY; CANCER GRADING; CONTRAST ENHANCEMENT; GLIOMA; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; TREATMENT OUTCOME;

BIOMEDICAL RESEARCH; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; GADOLINIUM; GLIOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING;

EID: 9144234893     PISSN: 07395175     EISSN: None     Source Type: Journal    
DOI: 10.1109/MEMB.2004.1360406     Document Type: Review

References (82)

1. M.D. Prados, "Treatment strategies for patients with recurrent brain tumors," Semin. Radiol. Oncol., vol. 1, pp. 62-68, 1991.
2. S.A. Liebel, C.B. Scott, and J.S. Loeffler, "Contemporary approaches to the treatment of malignant gliomas with radiation therapy," Semin. Oncol., vol. 21, pp. 198-219, 1994.
3. C.C. Boring, T.S. Squires, and R. Tong, "Cancer statistics," CA Cancer J. Clin., vol. 42, no. 1, pp. 7-26, 1992.
4. D.S. Russell and L.J. Rubenstein, Pathology of Tumors of the Nervous System, 5th Ed. London, U.K.: Williams & Wilkins, 1989.
5. P. Kleihues, P.C. Burger, and B.W. Scheithauer, Histological Typing of Tumours of the Central Nervous System, 2nd Ed. Berlin, Germany: Springer-Verlag, 1993.
6. J.B. Posner, "Brain metastases: A clinician's view," in Brain Metastases, L. Weiss, H.A. Gilbert, and J.B. Posner, Eds. Boston, MA: GK Hill, 1980, pp. 2-29.
7. K.E. Wallner, J.H. Galicich, G. Krol, E. Arbit, and M.G. Malkin, "Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma," Int. J. Radiat. Oncol. Biol. Phys., vol. 16, no. 6, pp. 1405-1409, 1989.
8. F.C.H. Chu and B.B. Hilaris, "Value of radiation therapy in the management of intracranial metastases," Cancer, vol. 14, pp. 577-581, 1961.
9. S. Zimm, G.L. Wampler, D. Stablein, T. Hazra, and H.F. Young, "Intracerebral metastases in solid tumor patients: Natural history and results of treatment," Cancer, vol. 48, no. 2, pp. 384-394, 1981.
10. M.P. Mehta, J.M. Rozental, A.B. Levin, T.R. Mackie, S.S. Kubsad, M.A. Gehring, and T.J. Kinsella, "Defining the role of radiosurgery in the management of brain metastases," Int. J. Radiat. Oncol. Biol. Phys., vol. 24, no. 4, pp. 619-625, 1992.
11. S. Leibel, P. Gutin, P. Sneed, M.D. Prados, K. Levin, D. Larson, W. Wara, and T. Phillips, "Interstitial irradiation for the treatment of primary and metastatic brain tumors," in Cancer: Principles and Practice of Oncology Update Series, vol. 3, V.T. DeVita, S. Hellman, and S.A. Rosenberg, Eds. Philadelphia, PA: Lippincott, Williams, and Wilkins, pp. 1-11, 1989.
12. S.A. Leibel, P.H. Gutin, W.M. Wara, P.S. Silver, D.A. Larson, M.S.B. Edwards, S.A. Lamb, B. Ham, K.A. Weaver, C. Barnett, and T.L. Phillips, "Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas," Int. J. Radiat. Oncol. Biol. Phys., vol. 17, no. 6, pp. 1129-1139, 1989.
13. P.M. Gutin, M.D. Prados, T.L. Phillips, W.M. Wara, D.A. Larson, S.A. Leibel, P.K. Sneed, V.A. Levin, K.A. Weaver, P. Silver, K. Lamborn, S. Lamb, and B. Ham, "External irradiation followed by an interstitial high activity iodine-125 implant boost in the initial treatment of malignant gliomas: NCOG study 6G-82-2," Int. J. Radiat. Oncol. Biol. Phys., vol. 21, no. 3, pp. 601-606, 1991.
14. J.C. Flickinger, D. Kondziolka, L.D. Lunsford, R.J. Coffey, M.L. Goodman, E.G. Shaw, W.R. Hudgins, R. Weiner, G.R. Harsh IVth, and P.K. Sneed, "A multi-institutional experience with stereotactic radiosurgery for solitary brian metastases," Int. J. Radiat. Oncol. Biol. Phys., vol. 28, no. 4, pp. 797-802, 1994.
15. T.M. Moriarty, J.S. Loeffler, P.M. Black, D.C. Shrieve, P.Y. Wen, H.A. Fine, H.M. Kooy, and E. Alexander, "Long term follow-up of patients treated with stereotactic radiosurgery for single or multiple brain metastases," in Radiosurgery, vol. 1, D. Kondziolka, Ed. Basel, Switzerland: Karger, 1995, pp. 83-91.
16. T. Kurki, N. Lundbom, H. Kalimo, and S. Valtonen, "MR classification of brain gliomas: Value of magnetization transfer and conventional imaging," Magn. Resort. Imag., vol. 13, no. 4, pp. 501-511, 1995.
17. T.J. Vogl, C.E. Friebe, T. Balzer, M.G. Mack, S. Steiner, H. Schedel, W. Pegios, W. Lanksch, D. Banzer, and R. Felix, "Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intra-individual evaluation of a phase II high dose study," Radiology, vol. 35, no. 8, pp. 508-516, 1995.
18. S.J. Nelson, A.B. Nalbandian, E. Proctor, and D.B. Vigneron, "Registration of images from sequential MR examinations of the brain," J. Magn. Reson. Imag., vol. 4, no. 6, pp. 877-883, 1994.
19. C.A. Pelizzari, G.T.Y. Chen, D.R. Spelbring, R.R. Weichselbaum, and C.T. Chen, "Accurate three-dimensional registration of CT, PET, and/or MR images of the brain," J. Comput. Assist. Tomog., vol. 13, no. 1, pp. 20-26, 1989.
20. U. Pietrzyk, K. Herholz, and W.D. Heiss, "Three-dimensional alignment of functional and morphological tomograms," J. Comput. Assist. Tomog., vol. 14, no. 1, pp. 51-59, 1990.
21. W.T. Yuh, H.D. Nguyen, E.T. Tali, N.A. Mayr, D.J. Fisher, S.W. Atlas, M.C. Carvlin, B.P. Drayer, S.R. Pollei, and V.M. Runge, "Delineation of gliomas with various doses of MR contrast material," Amer. J. Neuroradiology, vol. 15, no. 5, pp. 983-989, 1994.
22. J.N. Rydberg, C.A. Hammond, R.C. Grimm, B.J. Erickson, C.R. Jack Jr., J. Huston, III, and S.J. Riederer, "Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence," Radiology, vol. 193, no. 1, pp. 173-180, 1994.
23. B. De Coene, J.V. Hajnal, P. Gatehouse, D.B. Longmore, S.J. White, A. Oatridge, J.M. Pennock, I.R. Young, and G.M. Bydder, "MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences," Amer. J. Neuroradiology, vol. 13, no. 6, pp. 1555-1564, 1992.
24. M.E. Moseley, M.F. Wendland, and J. Kucharczyk, "Magnetic resonance imaging of diffusion and perfusion," Topics in Magnetic Resonance Imaging, vol. 3, no. 3, pp. 50-67, 1991.
25. M.E. Moseley, J. Kucharczyk, H.S. Asgari, and D. Norman, "Anisotropy in diffusion-weighted MRI," Magn. Reson. Med., vol. 19, no. 2, pp. 321-326, 1991.
26. T. Sugahara, Y. Korogi, M. Kochi, I. Ikushima, Y. Higematu, T. Hirai, T. Okuda, L. Liang, Y. Ge, Y. Komohara, Y. Ushio, and M. Takahashi, "Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas," J. Magn. Reson. Imag., vol. 9, no. 1, pp. 53-60, 1999.
27. C.R. Fisel, J.L. Ackerman, R.B. Buxton, L. Garrido, J.W. Belliveau, B.R. Rosen, and T.J. Brady, "MR contrast due to microscopically heterogeneous magnetic susceptibility: Numerical simulations and applications to cerebral physiology," Magn. Reson. Med., vol. 17, no. 2, pp. 336-347, 1991.
28. R.R. Edelman, H.P. Mattle, D.J. Atkinson, T. Hill, J.P. Finn, C. Mayman, M. Ronthal, H.M. Hoogewoud, and J. Kleefield, "Cerebral blood flow: Assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T," Radiology, vol. 176, no. 1, pp. 211-220, 1990.
29. R.M. Weisskoff, J.L. Boxerman, A.G. Sorensen, S.M. Kulke, T.A. Campbell, and B.R. Rosen, "Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection," in Soc. Magnetic Resonance in Medicine (SMRM) Abstracts, 1994.
30. R.P. Kennan, J. Zhong, and J.C. Gore, "Intravascular susceptibility contrast mechanisms in tissues," Magn. Reson. Med., vol. 31, no. 1, pp. 9-21, 1994.
31. K.B. Larson, W.H. Perman, J.S. Perlmutter, M.H. Gado, J.M. Ollinger, and K. Zierler, "Tracer-kinetic analysis for measuring regional cerebral blood flow by dynamic nuclear magnetic resonance imaging," J. Theor. Biol., vol. 170, no. 1, pp. 1-14, 1994.
32. B.R. Rosen, J.W. Belliveau, and D. Chien, "Perfusion imaging by nuclear magnetic resonance," Magn. Reson. Quar., vol. 5, no. 4, pp. 263-281, 1989.
33. S. Brem, R. Cotran, and J. Folkman, "Tumor angiogenesis: A quantitative method for histologic grading," J. Natl. Cancer Inst., vol. 48, no. 2, pp. 347-356, 1972.
34. P. Macchiarini, G. Fontanini, M.J. Hardin, F. Squartini, C.A. Angeletti, "Relation of neovascularization to metastases of non-small-cell lung cancer," Lancet, vol. 340, no. 8812, pp. 145-146, 1992.
35. P. Black, "Brain tumors," New Eng. J. Med., vol. 324, no. 21, pp. 1471-1476, 1991.
36. H.J. Aronen, I.E. Gazit, D.N. Louis, B.R. Buchbinder, F.S. Pardo, R.M. Weisskoff, G.R. Harsh, C.R. Cosgrove, E.F. Halpern, F.H. Hochberg, and B.R. Rosen, "Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings," Radiology, vol. 191, no. 1, pp. 41-51, 1994.
37. F.S. Pardo, H.J. Aronen, D. Kennedy, G. Moulton, K. Paiva, P. Okunieff, E.V. Schmidt, F.H. Hochberg, G.R. Harsh, A.J. Fischman, R.M. Linggood, and B.R. Rosen, "Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma," Int. J. Radiat. Oncol. Biol. Phys., vol. 30, no. 3, pp. 663-669, 1994.
38. J.D. Glickson, "Clinical NMR spectroscopy of tumors. Current status and future directions," Invest. Radiol., vol. 24, no. 12, pp. 1011-1016, 1989.
39. D.L. Arnold, E.A. Shoubridge, J.G. Villemure, and W. Feindel, "Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading," NMR Biomed., vol. 3, no. 4, pp. 184-189, 1990.
40. J.H. Langkowski, J. Wieland, H. Bomsdorf, D. Leibfritz, M. Westphal, W. Offermann, and R. Maas, "Pre-operative localized in vivo proton spectroscopy in cerebral tumors at 4.0 Tesla-First results," J. Magn. Reson. Imag., vol. 7, no. 5, pp. 547-555, 1989.
41. P. Demaerel, K. Johannik, P. Van Hecke, C. Van Ongeval, S. Verellen, G. Marchal, G. Wilms, C. Plets, J. Goffin, F. Van Calenbergh, M. Lammens, and A.L. Baert, "Localized 1H NMR spectroscopy in fifty new cases of newly diagnosed intracranial tumors," J. Cat. Asst. Tomogr., vol. 15, no. 1, pp. 67-76, 1991.
42. J.R. Alger, J.A. Frank, A. Bizzi, M.J. Fulham, B.X. DeSouza, M.O. Duhaney, S.W. Inscoe, J.L. Black, P.C.M. van Zijl, C.T.W. Moonen, and G. Di Chiro, "Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 flourodeoxyglucose PET," Radiology, vol. 177, no. 3, pp. 633-641, 1990.
43. S.S. Gill, D.G. Thomas, N. Van Bruggen, D.G. Gadian, C.J. Peden, J.D. Bell, IJ. Cox, D.K. Menon, R.A. Iles, and D.J. Bryant, "Proton MR spectroscopy of intracranial tumors: In vivo and in vitro studies," J. Comp. Asst. Tomogr., vol. 14, no. 4, pp. 497-504, 1990.
44. H. Kugel, W. Heindel, R.I. Ernestus, J. Bunke, R. du Mesnil, and G. Friedman, "Human brain tumors: Spectral patterns detected with localized H-1 MR spectroscopy," Radiology, vol. 183, no. 3, pp. 701-709, 1992.>
45. P.B. Barker, J.D. Glickson, and R.N. Bryan, "In vivo magnetic resonance of human brain tumors," Top Magn. Reson. Imag., vol. 5, no. 1, pp. 32-45, 1993.
46. L. Chang, D. McBride, B.L. Miller, M. Cornford, R.A. Booth, S.D. Buchthal, T.M. Ernst, and D. Jenden, "Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of hetergeneous brain tumors," J. Neuroimaging, vol. 5, no. 3, pp. 157-163, 1995.
47. D.Q. McBride, B.L. Miller, D.L. Nikas, S. Buchthal, L. Chang, F. Chiang, and R.A. Booth, "Analysis of brain tumors using 1H magnetic resonance spectroscopy," Surgical Neurology, vol. 44, no. 2, pp. 137-144, 1995.
48. J.P. Usenius, R.A. Kauppinen, P. Vaino, J.A. Hernesniemi, M.P. Vapalahti, L.A. Paljarvi, and S. Soimakallio, "Quantitative metabolite patterns of human brain tumors: Detection by 1H NMR spectroscopy in vivo and in vitro," J. Comput. Assist. Tomogr., vol. 18, no. 5, pp. 705-713, 1994.
49. J.P. Usenius, P. Vainio, J. Hernesniemi, and R.A. Kauppinen, "Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro," J. Neurochem., vol. 63, no. 4, pp. 1538-1543, 1994.
50. W.G. Negendank, R. Sauter, T.R. Brown, J.L. Evelhoch, A. Falini, E.D. Gotsis, A. Heerschap, K. Kamada, B.C. Lee, M.M. Mengeot, E. Moser, K.A. Padavic-Shaller, J.A. Sanders, T.A. Spraggins, A.E. Stillman, B. Terwey, T.J. Vogl, K. Wicklow, and R.A. Zimmerman, "Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study," J. Neurosurg., vol. 84, no. 3, pp. 449-458, 1996.
51. P.E. Sijens, M.V. Knopp, A. Brunetti, K. Wicklow, B. Alfano, P. Bachert, J.A. Sanders, A.E. Stillman, H. Kelt, R. Sauter, et al., "1H MR spectroscopy in patients with metastatic brain tumors: A multicenter study," Magn. Reson. Med., vol. 33, no. 6, pp. 818-826, 1995.
52. M.A. Heesters, R.L. Kamman, E.L. Mooyaart, and K.G. Go, "Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy," J. Neurooncol., vol. 17, no. 1, pp. 27-35, 1993.
53. H. Shimizu, T. Kumabe, T. Tominaga, T. Kayama, K. Kara, Y. Ono, K. Sato, N. Arai, S. Fujiwara, and T. Yoshimoto, "Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy," Amer. J. Neuroradiol., vol. 17, no. 4, pp. 737-747, 1996.
54. C.M. Segebarth, D.F. Baleriaux, P.R. Luyten, and J.A. den Hollander, "Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging," Magn. Reson. Med., vol. 13, no. 1, pp. 62-76, 1990.
55. P.R. Luyten, A.J. Marien, W. Heindel, G.P. Van, K. Herholz, J. den Hollander, G. Friedmann, and W.D. Heiss, "Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscoptc imaging and PET," Radiology, vol. 176, no. 3, pp. 791-799, 1990.
56. M.J. Fulham, A. Bizzi, M.J. Dietz, H.H. Shih, R. Raman, G.S. Sobering, J.A. Frank, A.J. Dwyer, J.R. Alger, and G. Di Chiro, "Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance," Radiology, vol. 185, no. 3, pp. 675-686, 1992.
57. 11C] Tyrosine positron emission tomography to localization of cerebral gliomas for biopsy," Neurosurg., vol. 34, no. 6, pp. 994-1002, 1994.
58. M.C. Preul, Z. Caramanos, D.L. Collins, J.G. Villemure, R. Leblanc, A. Olivier, R. Pokrupa, and D.L. Arnold, "Accurate non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy," Nature Medicine, vol. 2, no. 3, pp. 323-325, 1996.
59. S.J. Nelson, D.B. Vigneron, and W. Dillon, "Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI," NMR in Biomed, vol. 12, no. 3, pp. 123-138, 1999.
60. M.L. Simmons, C.G. Frondoza, and J.T. Coyle, "Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies," Neuroscience, vol. 45, no. 1, pp. 37-45, 1991.
61. X. Li, D.B. Vigneron, S. Cha, E.E. Graves, F. Crawford, S. Chang, and S.J. Nelson, "Relationship of MR-derived lactate, mobile lipids, and relative blood volume for in vivo gliomas," Amer. J. Neuroradiology, to be published.
62. Pirzkall, T.R. McKnight, E.E. Graves, M.P. Carol, P.K. Sneed, W.W. Wara, S.J. Nelson, L.J. Verhey, and D.A. Larson, "MR-spectroscopy guided target delineation for high-grade gliomas," Int. J. Radiat. Oncol. Biol. Phys., vol. 50, no. 4, pp. 915-928, 2001.
63. Pirzkall, S.J. Nelson, T.R. McKnight, M.M. Takahashi, X. Li, E.E. Graves, L.J. Verhey, W.W. Wara, D.A. Larson, and P.K. Sneed, "Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy," Int. J. Radiat. Oncol. Biol. Phys., vol. 53, no. 5, pp. 1254-1264, 2002.
64. A. Pirzkall, X. Li, J. Oh, S. Chang, M.S. Berger, D.A. Larson, L.J. Verhey, W.F. Dillon, and S.J. Nelson, "3D MRSI for resected high-grade gliomas before RT: Tumor extent according to metabolic activity in relation to MRI," Int. J. Radiat. Oncol. Biol. Phys., vol. 59, no. 1, pp. 126-137, 2004.
65. R.G. Henry, D.B. Vigneron, N.J. Fischbein, P.E. Grant, M.R. Day, S.M. Noworolski, J.M. Star-Lack, L.L. Wald, W.P. Dillon, S.M. Chang, and S.J. Nelson, "Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas," Amer. J. Neuroradiol., vol. 21, no. 2, pp. 357-366, 2000.
66. E.A. Knopp, S. Cha, G. Jonhson, A. Mazumdar, J.G., Golfmos, D. Zagzag, D.C. Miller, P.J. Kelly, I.I. Kricheff, "Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging," Radiology, vol. 211, no. 3, pp. 791-798, 1999.
67. J. Oh, R.G. Henry, A. Pirzkall, Y. Lu, X. Li, I. Catalaa, S.M. Chang, W.P. Dillon, and S.J. Nelson, "Survival analysis in patients with glioblastoma multiforme: Predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume," J. Magn. Reson. Imag., vol. 19, no. 5, pp. 546-554, 2004.
68. X. Li, H. Jin, Y. Lu, J. Oh, S.M. Chang, and S.J. Nelson, "Identification of MRI and IH MRSI parameters that may predict survival for patients with malignant gliomas," NMR in Biomed, vol. 17, no. 1, pp. 10-20, 2003.
69. 1H-spectroscopy in Gamma Knife radiosurgery of recurrent malignant gliomas," Neurosurgery, vol. 46, no. 2, pp. 319-328, 2000.
70. G. Tedeschi, N. Lundbom, R. Raman, S. Bonavita, J.H. Duyn, J.R. Alger, and G. Di Chiro, "Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study," J. Neurosurgery, vol. 87, no. 4, pp. 516-524, 1997.
71. K. Kamada, K. Houkin, H. Abe, Y. Sawamura, and T. Kashiwaba, "Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy," Neurologia Medico-Chirurgica, vol. 37, no. 3, pp. 250-256, 1997.
72. J.S. Taylor, J.W. Langsten, W.E. Reddick, P.B. Kingsley, R.J. Ogg, M.H. Pui, L.E. Run, J.J. Jenkins, III, G. Chen, J.J. Ochs, R.A. Sanford, and R.L. Heideman, "Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis," Int. J. Radiat. Oncol. Biol. Phys., vol. 36, no. 5, pp. 1251-1261, 1996.
73. S.L. Sailer, J.G. Rosenman, M. Soltys, T.J. Cullip, and J. Chen, "Improving treatment planning accuracy through multimodality imaging," Int. J. Radiat. Oncol. Biol. Phys., vol. 35, no. 1, pp. 117-124, 1996.
74. T. Usenius, J.P. Usenius, M. Tenhunen, P. Vainio, R. Johansson, S. Soimakallio, and R. Kauppinen, "Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo," Int. J. Radiat. Oncol. Biol. Phys., vol. 33, no. 3, pp. 719-724, 1995.
75. H. Ikehira, T. Miyamoto, T. Yasukawa, T. Obata, H. Katoh, M. Koga, M. Yoshikawa, K. Yoshida, and Y. Tateno, "Differences in metabolic and morphological reactions after radiation therapy: Proton NMR spectroscopy and imaging of patients with intracranial tumors," Rad. Med., vol. 13, no. 5, pp. 199-204, 1995.
76. M.C. Lee, A. Pirzkall, T.R. McKnight, and S.J. Nelson, "1H-MRSI of radiation effects in normal appearing white matter: Dose-dependence and impact on automated spectral classification," J. Magn. Reson. Imag., vol. 19, no. 4, pp. 379-388, 2004.
77. F. Esteve, C. Rubin, S. Grand, H. Kolodie, and J.F. Le Bas, "Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy," Int. J. Radiat. Oncol. Biol. Phys., vol. 40, no. 2, pp. 279-286, 1998.
78. L.L. Wald, S.J. Nelson, M.R. Day, S.E. Noworolski, R.G. Henry, S.L. Huhn, S.M. Chang, M.D. Prados, P.K. Sneed, D.A. Larson, W.M. Wara, M. McDermott, W.P. Dillon, P.H. Gutin, and D.B. Vigneron, "Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy," J. Neurosurg., vol. 87, no. 4, pp. 25-34, 1997.
79. S.J. Nelson, S. Huhn, D.B. Vigneron, M.R. Day, L.L. Wald, M. Prados, S.M. Chang, P. Gutin, P.K. Sneed, L.J. Verhey, R.A. Hawkins, and W.P. Dillon, "Volume MRI and MRSI techniques for the quantization of treatment response in brain tumors," J. Magn. Reson. Imag., vol. 7, no. 6, pp. 1146-1152, 1997.
80. S.J. Nelson, E.E. Graves, A. Pirzkall, X. Li, A.A. Chan, D.B. Vigneron, and T.R. McKnight, "In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI," J. Magn. Reson. Imag., vol. 16, no. 4, pp. 464-476, 2002.
81. A. Chan, A. Lau, A. Pirzkall, S.M. Chang, L. Verhey, D. Larson, M.W. McDermott, W.P. Dillon, and S.J. Nelson, "Proton magnetic resonance spectroscopic imaging as a tool for evaluating grade IV glioma patients undergoing Gamma knife radiosurgery," J. Neurosurg, 101, no. 3, Sept. 2004.
82. T.R. McKnight, S.M. Noworolski, D.B. Vigneron, and S.J. Nelson, "An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma," J. Magn. Reson. Imag., vol. 13, no. 2, pp. 167-177, 2001.